Why can megaloblastic anemia mimic hemochromatosis?

Megaloblastic Anemia Can Mimic Hemochromatosis Through Elevated Ferritin and Transferrin Saturation

Megaloblastic anemia mimics hemochromatosis because both conditions can present with elevated serum ferritin and increased transferrin saturation, creating diagnostic confusion—however, the key distinguishing feature is that hemochromatosis occurs in the absence of anemia and reticulocytosis, while megaloblastic anemia presents with macrocytic anemia. 1

The Diagnostic Confusion: Understanding the Overlap

The 2022 EASL guidelines explicitly define hemochromatosis as occurring "in the absence of anaemia and/or reticulocytosis" 1. This is the critical distinguishing feature that clinicians must recognize. When megaloblastic anemia is present, several laboratory abnormalities can falsely suggest hemochromatosis:

Why the Mimicry Occurs

Elevated ferritin in megaloblastic anemia results from:

• Ineffective erythropoiesis causing increased iron turnover
• Tissue damage and inflammation releasing ferritin
• Decreased iron utilization despite adequate or elevated iron stores

Increased transferrin saturation can occur because:

• Iron is not being effectively incorporated into hemoglobin during the defective DNA synthesis of megaloblastic anemia
• This creates a relative excess of circulating iron despite the underlying anemia

The Critical Distinguishing Features

Look for These Red Flags Against Hemochromatosis:

1. Presence of anemia - Hemochromatosis patients should NOT be anemic 1
2. Macrocytosis with hypersegmented neutrophils - Classic for megaloblastic anemia 2, 3, 4
3. Low or inappropriately normal reticulocyte count - Indicates ineffective erythropoiesis, not hemolysis 2, 3
4. Elevated LDH with low haptoglobin - This combination mimics hemolysis but actually reflects ineffective erythropoiesis in megaloblastic anemia 2, 3

The Algorithmic Approach to Differentiation:

Step 1: Check hemoglobin and MCV

• If anemic with macrocytosis → NOT hemochromatosis, consider megaloblastic anemia
• If normal hemoglobin with elevated ferritin/TSAT → proceed with hemochromatosis workup

Step 2: Examine the peripheral smear

• Hypersegmented neutrophils and megaloblastic changes → megaloblastic anemia 2, 3, 4
• Normal morphology → continue hemochromatosis evaluation

Step 3: Check reticulocyte count

• Low or inappropriately normal with anemia → ineffective erythropoiesis (megaloblastic) 2, 3
• Elevated → consider true hemolysis or other causes

Step 4: Measure B12 and folate levels

• If deficient → diagnose and treat megaloblastic anemia first
• If normal → proceed with HFE genetic testing for hemochromatosis 1

Common Clinical Pitfalls to Avoid

Do not initiate phlebotomy based solely on elevated ferritin and transferrin saturation without confirming the absence of anemia. The case report of a patient with congenital dyserythropoietic anemia and hemochromatosis demonstrates that phlebotomy in an anemic patient can cause severe complications 5. This patient developed severe anemia after just a few phlebotomies, highlighting the danger of misdiagnosis.

Do not assume hemolysis when you see elevated LDH and low haptoglobin. Multiple recent case reports 2, 3, 4 emphasize that megaloblastic anemia creates a "pseudo-hemolytic" picture through ineffective erythropoiesis. The combination of these markers with a LOW reticulocyte count should immediately redirect you toward megaloblastic anemia rather than hemolysis or hemochromatosis.

Do not overlook dietary history and medication use. Long-term proton pump inhibitor use is a common contributor to B12 deficiency 2, and detailed nutritional assessment can reveal vitamin C deficiency causing megaloblastic changes 4.

The Rare But Important Coexistence

While rare, both conditions can coexist in the same patient 5. In such cases, genetic testing for HFE mutations becomes essential to identify true hemochromatosis, but treatment must be carefully managed to avoid worsening anemia through phlebotomy. Always correct the megaloblastic anemia with vitamin replacement before considering phlebotomy, even if genetic hemochromatosis is confirmed.

Treatment Implications

Once megaloblastic anemia is identified:

• Initiate vitamin B12 and/or folate replacement immediately
• Discontinue contributing medications (PPIs, metformin, etc.) 2
• Expect rapid hematologic improvement within days to weeks 2, 3
• Recheck iron parameters after correction of the anemia to determine if true iron overload exists

The EASL guidelines specify that hemochromatosis diagnosis in non-C282Y homozygotes requires documented hepatic iron overload on MRI or biopsy 1, which provides an additional safeguard against misdiagnosis when iron parameters are ambiguous.